iiinova — where your digital self keeps evolving

Yudisthra Ganeshadeva @yudisthra.bsky.social · 28/08/2026

Nepal Flood Disaster Relief fund via their Prime Ministers Office

Yudisthra Ganeshadeva @yudisthra.bsky.social · 13/07/2026

#AskRenal I have a 72 year old on Automated PD since 2022 who initially defaulted PD for months and once recommenced on PD developed vomiting while on PD. Non compliant to follow-up and his last PET test in early 2023 showed a HA transporter.

100

Reposted by Yudisthra Ganeshadeva

Nephrology Journal Club @nephjc.bsky.social · 22/04/2026

Still ordering hydralazine? 🤔 Beyond case reports, this large cohort compares hydralazine vs ACEi/ARB to estimate real-world vasculitis risk, will this 📉 bias & clarify the answer Read more 👇 pubmed.ncbi.nlm.nih.... #TenPostNephJC #NephJC #NephSky #MedSky

168

Reposted by Yudisthra Ganeshadeva

ASN Publications @asnpublications.bsky.social · 21/04/2026

Nursing Home-based dialysis is growing quickly and now forms a significant part of home hemodialysis. Further research is necessary on hospitalization, mortality, functional status, and return-to-home outcomes specific to each type. kidney.pub/JASN1109

011

Reposted by Yudisthra Ganeshadeva

Krutika Kuppalli, MD FIDSA @krutikakuppalli.bsky.social · 20/04/2026

Late-breaking #Lancet SCOUT RCT results at #ESCMIDGlobal2026: 💊 Day 7 clinical resolution • Nitrofurantoin: 74% • Pivmecillinam: 70% • Fosfomycin (2 doses): 67% • Fosfomycin (single dose): 59% 🔑 single-dose fosfomycin underperforms vs standard short-course regimens

32610

Yudisthra Ganeshadeva @yudisthra.bsky.social · 21/04/2026

Quick question - if I want to give Cefoperazone-Sulbactam for IP antibiotics for Automated PD with 10L exchanges can I use the Cefoperazone data in ISPD guidelines ie 500mg/L loading with 125mg/L for maintainence or is that overkill? #AskRenal

111

Reposted by Yudisthra Ganeshadeva

ISNkidneycare @theisn.org · 31/10/2025

🎥 Explore the onconephrology case presentation series on the ISN Academy, in collaboration with ASON. Tackle real-world challenges in cancer & kidney care. 📌 Latest case: AKI post haematopoietic stem cell transplantation (HSCT) 👉https://academy.theisn.org/onconephrologycases

031

Yudisthra Ganeshadeva @yudisthra.bsky.social · 31/10/2025

Patient on Automated PD presents with hypotension, abdominal pain , fever for 2 days. Symptoms developed after colonoscopy with polypectomy.

132

Yudisthra Ganeshadeva @yudisthra.bsky.social · 13/03/2025

Pseudoaneurysm of dialysis fistula with impending rupture #POCUS

020

Reposted by Yudisthra Ganeshadeva

Alex Chang, MD @alexchangmd.bsky.social · 02/03/2025

Awesome #nephmadness write up about resistant #hypertension renal denervation vs. novel drugs @stephanietr612.bsky.social @jordybc.bsky.social and visual abstracts @nephroseeker.medsky.social …And troubling AI-generated kidney art with tablet-shaped electroshockers i@littlebiggloms.bsky.social

1128

Reposted by Yudisthra Ganeshadeva

Joel Topf @kidneyboy.bsky.social · 03/03/2025

Medtronic pulling out of the endovascular fistula creation market. Wow. This is from the American Society of Diagnostic and Interventional Nephrology. And can't find this information on the medtronic website or with google. That may be a me problem though.

Dear ASDIN Members:
Due to the importance of this message below to our field, ASDIN is sharing the Medtronic media statement with our membership. ASDIN will continue to advocate on behalf of our members and will work with other providers to continue availability of endoAVF options for patients.
Medtronic Statement
Medtronic has made the decision to discontinue offering the Ellipsys ™ Vascular Access System for arteriovenous fistula (AVF) creation in all geographies. In a commitment to our customers, we will ensure they have up to 12 months of supply and up to six months of field, clinical, and cannulation support and will work closely with stakeholders to transition to alternative fistula creation solutions over the coming months.
This decision will not limit patient or physician options for fistula creation. As the current standard of care, surgical fistula creation remains an option for any patient who would be a candidate for the Ellipsys system and an alternative endovascular fistula creation technology is commercially available in the U.S. and other regions.
Medtronic remains committed to the arteriovenous market, focusing on effective fistula maintenance with our IN.PACTT™ AV drug-coated balloon and the Fortrex ™ HP PTA balloon catheter. While this was a difficult decision, this strategic shift will enable us to prioritize our resources towards fostering innovation and developing new therapies where we can have the most significant impact. This decision is aligned to Medtronic's active portfolio management work, an important lever to delivering on the company's long-term strategic and financial objectives.

4115

Yudisthra Ganeshadeva @yudisthra.bsky.social · 03/03/2025

TCC at right PUJ causing right obstructive uropathy. Growing into proximal ureter #POCUS

020

Yudisthra Ganeshadeva @yudisthra.bsky.social · 03/03/2025

TCC at the PUJ of the Right Kidney causing obstructive uropathy

000

Yudisthra Ganeshadeva @yudisthra.bsky.social · 07/02/2025

Can subcut Rituximab be used in Lupus Nephritis? Would save a lot of time

000

Yudisthra Ganeshadeva @yudisthra.bsky.social · 24/01/2025

Amazing that people think anyone misses X as a site for professional development. To me personally X will remain just a place to catch up on news and occasionally criticize politicians in my country

010

Reposted by Yudisthra Ganeshadeva

CJKHD @cjkhd.bsky.social · 24/01/2025

Research shows that COVID-19 vaccination reduces the risk of AKI and 28-day mortality in hospitalized patients with severe COVID-19. 📉💉 Learn more about the protective effects of vaccination! @Froylan_EndoMD @cjkhd.bsky.social @csnscn.bsky.social #COVID19 #Vaccination #KidneyHealth #CJKHD

A Kaplan-Meier survival curve showing cumulative survival over a 28-day in-hospital stay period for four groups: "Vaccinated without AKI" (blue line), "Vaccinated with AKI" (red line), "Not Vaccinated without AKI" (green line), and "Not Vaccinated with AKI" (orange line). The x-axis represents in-hospital stay in days, and the y-axis represents cumulative survival. The survival rate decreases more sharply in the "Not Vaccinated with AKI" group, followed by the "Vaccinated with AKI" group. The "Vaccinated without AKI" group has the highest survival, followed by the "Not Vaccinated without AKI" group. A log-rank test shows a p-value of 0.026, indicating a statistically significant difference in survival between the groups.

031

Reposted by Yudisthra Ganeshadeva

𝑀𝒶𝓎𝓇𝒶°❀⋆.ೃ࿔*:･🫧 @lepapillonblue.bsky.social · 31/12/2024

Please pass this along, thank you.

208108366445

Yudisthra Ganeshadeva @yudisthra.bsky.social · 31/12/2024

Happy New Year 2025 guys And Happy Hannukah as well

010

Reposted by Yudisthra Ganeshadeva

Nico Dauby MD PhD @infectiobxl.bsky.social · 29/12/2024

Fatal dengue virus infection in an unvaccinated traveler (from Guadeloupe) "We present a fatal case of severe dengue in an unvaccinated traveler without known prior dengue virus infection but longitudinal serologic and molecular evidence for secondary infection" link.springer.com/article/10.1...

link.springer.com

Fatal dengue virus infection in an unvaccinated traveler - European Journal of Clinical Microbiology & Infectious Diseases

Dengue is an increasing threat to individuals living in or visiting endemic countries. Effective vaccines have become available, but their use in travelers is typically only recommended to individuals...

073

Reposted by Yudisthra Ganeshadeva

Samir S. Shah @samirshahmd.bsky.social · 28/12/2024

🧪Incredible story of the triumph of science and humanity. Neil Willenson founded the camp in the early 90s at the age of 22‼️ #MedSky I'm not sure anyone in the late 80s or early 90s imagined a day like this would come.

0239

Reposted by Yudisthra Ganeshadeva

grahamabra.bsky.social @grahamabra.bsky.social · 26/12/2024

This is interesting. Given you can see extensive replacement of the kidneys in ADPKD with a relatively normal Cr, find it hard to believe that a few medullary cysts are causative of progressive CKD risk but maybe they are a marker of various know/unknown genetic predisposition to progression?

043

Reposted by Yudisthra Ganeshadeva

Randall Munroe @xkcd.com · 26/12/2024

Sun Avoidance xkcd.com/3029

443805290

Reposted by Yudisthra Ganeshadeva

American Journal of Kidney Diseases @ajkd.bsky.social · 22/12/2024

#RenalPath Cellular variant of focal segmental glomerulosclerosis, with endocapillary hypercellularity with foam cells and mononuclear cells (top; Jones silver stain). bit.ly/4gtY4KZ (FREE)

065

Yudisthra Ganeshadeva @yudisthra.bsky.social · 21/12/2024

Opening plenary by Dr @chekloong the next KKM Head of service for Nephrology at #MSDIN2024. Mortality appears to be increased with each era. Possibly due to increased use of hemodialysis catheters . Japan mortality low and has only 1.6% catheter use

150

Reposted by Yudisthra Ganeshadeva

narjes-alamri.bsky.social @narjes-alamri.bsky.social · 04/12/2024

I have heard of uremic seizure but never saw it until recently. There’s always a first.

021

Reposted by Yudisthra Ganeshadeva

Joel Topf @kidneyboy.bsky.social · 07/09/2016

I'm just shocked that the recommended access for dialysis fails in over a third of patients. It's criminal #nephjc

262

Reposted by Yudisthra Ganeshadeva

God @thegodshow.com · 01/12/2024

So glad Bluesky is cracking down on impersonators and parody accounts. NOTE: Since no one can prove God is real, I am therefore not an impersonation or a parody. Hi, I’m God.

1388523982676

Reposted by Yudisthra Ganeshadeva

Hofstra Kidney @hofstrakidney.bsky.social · 01/12/2024

Our Onconephrology fellow project from 2023-2024 Dr Attieh www.dustri.com/nc/article-r... @kdjhaveri.bsky.social

042

Reposted by Yudisthra Ganeshadeva

Hofstra Kidney @hofstrakidney.bsky.social · 01/12/2024

www.era-online.org/publications... c3 GN podocyte puzzles @kdjhaveri.bsky.social

era-online.org

C3 Glomerulopathy | ERA

042

Yudisthra Ganeshadeva @yudisthra.bsky.social · 01/12/2024

Also for Nephrologists treating patients with pneumonia due to sinusitis in the dialysis unit

030

Reposted by Yudisthra Ganeshadeva

Jan Klocke @janklocke.bsky.social · 01/12/2024

To celebrate the growing #medsky / #nephsky community, I will post one silly med/kidney cartoon every day for one month! d21: throwback to that one time I did a whole six panel comic about pseudohyperkalemia...

2315

Yudisthra Ganeshadeva @yudisthra.bsky.social · 30/11/2024

50 year old gentleman , End Stage Kidney failure on dialysis since 2021 presents with feeling unwell after dialysis. He had a total parathyroidectomy done exactly 5 months ago.

131

Reposted by Yudisthra Ganeshadeva

Gary Singer @garysinger.bsky.social · 28/11/2024

Daughter (16) gets it - and wants to be a nephrologist! 🫘 #NephSky #MedSky

31126

Reposted by Yudisthra Ganeshadeva

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 10/11/2024

If you haven't already - please consider signing the ISN petition for the WHO to consider kidney health as a global priority We explain why with link to sign (takes 2 minutes - open to all) www.nephjc.com/news/isn-who...

nephjc.com

Making Kidney Health a Global Priority — NephJC

Let’s pus the WHO to make Kidney Health a global priority

12716

Reposted by Yudisthra Ganeshadeva

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 24/11/2024

🦋will hit 22 million users tonight 🐦 & 🧵 have many magnitudes more users But it’s the quality and not the quantity of users that gives BlueSky the edge, says @jaypeters.net at @theverge.com www.theverge.com/2024/11/23/2... h/t @kidneyboy.bsky.social via @scalzi.com

theverge.com

Twitter’s heir apparent isn’t X or Threads — it’s Bluesky

The blue bird is dead. Long live the blue sky.

69418